LFST — LifeStance Health Group, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1845257 ·
Last close
$14.17
Market Cap
$5.39B
52W High
$15.66
52W Low
$6.01
ADV30
5,487,095
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 455,864,000 | 161,402,000 | 33,077,000 | 22,385,000 | 2,186,283,000 | 218,818,000 | 693,892,000 |
| Jun 2026 | 435,354,000 | 153,041,000 | 30,653,000 | 23,612,000 | 2,181,496,000 | 225,943,000 | 704,348,000 |
| Mar 2026 | 403,476,000 | 135,932,000 | 22,284,000 | 14,243,000 | 2,145,882,000 | 194,797,000 | 668,466,000 |
| Dec 2025 | 382,195,000 | 126,295,000 | 18,084,000 | 11,668,000 | 2,203,933,000 | 248,642,000 | 682,918,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$217,868,000
Investing CF
$-53,001,000
Financing CF
$-127,853,000
CapEx
$-43,963,000
Dividends Paid
—
Buybacks
$-97,625,000
EPS Diluted TTM
$0.09
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-770,771,000
Inventory
—
Receivables
$110,960,000
ST Investments
—
EBIT TTM
$77,106,000
Pretax Income TTM
$66,992,000
Interest Exp TTM
$10,114,000
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,676,888,960
EBITDA
$161,054,000
Free Cash Flow
$163,492,752
Enterprise Value
$5,498,074,112
Total Cash
$218,818,000
Total Debt
$481,662,016
Shares Out
380,190,724
Trailing EPS
$0.18
Book Value
$3.92
ROE
4.8%
ROA
3.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,424,285,000 | 24,148,000 | 9,663,000 | 2,203,933,000 | 682,918,000 | 1,521,015,000 | 146,151,000 |
| Dec 2024 | 1,250,970,000 | -31,613,000 | -57,443,000 | 2,118,298,000 | 672,013,000 | 1,446,285,000 | 107,260,000 |
| Dec 2023 | 1,055,665,000 | -189,134,000 | -186,262,000 | 2,109,969,000 | 681,039,000 | 1,428,930,000 | -16,884,000 |
| Dec 2022 | 859,542,000 | -210,174,000 | -215,564,000 | 2,173,871,000 | 655,148,000 | 1,518,723,000 | 52,789,000 |
TTM Snapshot
Revenues TTM
$1,584,834,000
NetIncome TTM
$50,600,000
OpCashFlow TTM
—
Assets (Latest)
$2,181,496,000
Forward EPS
$0.43
Max Pain — expiry 2027-01-15
max pain strike: $8.00 · spot: $13.77 · call oi: 5,525 · put oi: 128
Expected Move to 2027-01-15:
±$1.50
(10.89%) —
implied range
$12.27 –
$15.27
· ATM straddle on $14.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CON | Concentra Group Holdings Parent, Inc. | $5.36B | $42.38 | — |
| CAI | Caris Life Sciences, Inc. | $5.72B | $19.94 | — |
| RDNT | RadNet, Inc. | $5.90B | $74.92 | — |
| GRAL | GRAIL, Inc. | $4.76B | $105.88 | — |
| OPCH | Option Care Health, Inc. | $4.74B | $31.63 | — |
News headlines (Yahoo Finance, 1h cache)
LifeStance, Private Equity Rollup Turned Organic Growth Stock, Targets A Profound Void
2026-11-13 21:19 · Yahoo
What iShares Russell 2000 Index Fund (IWM) Bought: LifeStance Leads on Nov. 11
2026-11-13 11:04 · Yahoo
LFST Q3 2026 deep dive: specialty services, clinician expansion, and EHR transition shape outlook
2026-11-10 10:29 · Yahoo
Surging Earnings Estimates Signal Upside for LifeStance Health (LFST) Stock
2026-11-09 16:20 · Yahoo
LifeStance Health Group Announces Pricing of Secondary Public Offering
2026-11-09 14:00 · Yahoo
LifeStance Health Group Announces Launch of Secondary Public Offering
2026-11-09 11:54 · Yahoo
Why LifeStance Health Group (LFST) Moved Today
2026-11-07 10:12 · Yahoo
What Makes LifeStance Health Group (LFST) a Strong Momentum Stock: Buy Now?
2026-11-06 16:00 · Yahoo
LifeStance Health Group, Inc. (LFST) Hits Fresh High: Is There Still Room to Run?
2026-11-06 13:15 · Yahoo
What LifeStance Health Group (LFST) Said on Its Q3 Earnings Call
2026-11-06 08:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.